[EN] PROCESS FOR PREPARING DASATINIB MONOHYDRATE<br/>[FR] PROCÉDÉ POUR LA PRÉPARATION DE DASATINIB MONOHYDRATÉ
申请人:SHILPA MEDICARE LTD
公开号:WO2013157019A2
公开(公告)日:2013-10-24
The present invention provides an improved process for preparing N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-l-piperazinyl]-2-methyl-4-pyrimidinyl] amino]-5-thiazole carboxamide monohydrate or Dasatinib monohydrate (Formula A).